Abstract
Genome-wide cancer mutation analyses are revealing an extensive landscape of functional mutations within the noncoding genome, with profound effects on the expression of long noncoding RNAs (lncRNAs). While the exquisite regulation of lncRNA transcription can provide signals of malignant transformation, we now understand that lncRNAs drive many important cancer phenotypes through their interactions with other cellular macromolecules including DNA, protein, and RNA. Recent advancements in surveying lncRNA molecular mechanisms are now providing the tools to functionally annotate these cancer-associated transcripts, making these molecules attractive targets for therapeutic intervention in the fight against cancer.
Cite
CITATION STYLE
Schmitt, A. M., & Chang, H. Y. (2016, April 11). Long Noncoding RNAs in Cancer Pathways. Cancer Cell. Cell Press. https://doi.org/10.1016/j.ccell.2016.03.010
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.